Bordetella pertussis fimbriae (Fim): relevance for vaccines

References

• Eldering G, Hornbeck C, Baker J. Serological study of Bordetella pertussis and related species. J Bacteriol 1957;74(2):133-6
   PubMedGoogle Scholar
• Ashworth L A, Irons LI, Dowsett A B. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infect Immun 1982;37(3):1278-81
   PubMedGoogle Scholar
• Ashworth LA, Robinson A, Funnell S, et al. Agglutinogens and fimbriae of Bordetella pertussis. Tokai J Exp Clin Med 1988;13(Suppl):203-10
   PubMedGoogle Scholar
• Steven A C, Bisher ME, Trus BL, et al. Helical structure of Bordetella pertussis fimbriae. J Bacteriol 1986;167(3):968-74
   PubMedGoogle Scholar
• Heck D V, Trus BL, Steven AC. Three-dimensional structure of Bordetella pertussis fimbriae. J Struct Biol 1996;116(2):264-9
   PubMedGoogle Scholar
• Geuijen CA, Willems RJ, Bongaerts M, et al. Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect Immun 1997;66(5):4222-8
   Google Scholar
• Hazenbos WL, van den Berg BM, Geuijen CW, et al. Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. J Immunol 1995;155(8):3972-8
   PubMed Web of Science ®Google Scholar
• Geuijen CA, Willems RJ, Mooi FR. The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars. Infect Immun 1996;64(7):2657-65
   PubMed Web of Science ®Google Scholar
• Geuijen CA, Willems RJ, Hoogerhout P, et al. Identification and characterization of heparin binding regions of the Fim2 subunit of Bordetella pertussis. Infect Immun 1998;66(5):2256-63
   PubMedGoogle Scholar
• Gorringe AR, Ashworth LAE, Irons LI, Robinson A. Effect of monoclonal antibodies on the adherence of Bordetella pertussis to Vero cells. FEMS Microbiol Lett 1985;6(1):5-9
   Google Scholar
• Rodríguez ME, Hellwig SM, Pérez Vidakovics ML, et al. Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies. FEMS Immunol Med Microbiol 2006;46(1):39-47
   PubMedGoogle Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014;111(2):787-92
   PubMed Web of Science ®Google Scholar
• Funnell SG, Robinson A. A novel adherence assay for Bordetella pertussis using tracheal organ cultures. FEMS Microbiol Lett 1993;110(2):197-203
   PubMedGoogle Scholar
• Pearce AM, Seabrook RN, Irons LI, et al. Localization of antigenic domains on the major subunits of Bordetella pertussis serotype 2 and 3 fimbriae. Microbiology 1994;140(1):205-11
   PubMedGoogle Scholar
• Robinson A, Gorringe A R, Funnell SG, Fernandez M. Serospecific protection of mice against intranasal infection with Bordetella pertussis. Vaccine 1989;7(4):321-4
   PubMedGoogle Scholar
• Alexander F, Matheson M, Fry NK, et al. Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease. Clin Vaccine Immunol 2012;19(11):1776-83
   PubMedGoogle Scholar
• Cowell JL, Zhang JM, Urisu A, et al. Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun 1987;55(4):916-22
   PubMedGoogle Scholar
• Parkhill J, Sebaihia M, Preston A, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003;35(1):32-40
   PubMed Web of Science ®Google Scholar
• Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 2010;10(1):36-49
   PubMed Web of Science ®Google Scholar
• Locht C, Geoffroy MC, Renauld G. Common accessory genes for the Bordetella pertussis filamentous hemagglutinin and fimbriae share sequence similarities with the papC and papD gene families. EMBO J 1992;11(9):3175-83
   PubMed Web of Science ®Google Scholar
• Harvill ET, Goodfield LL, Ivanov Y, et al. Genome sequences of 28 Bordetella pertussis U.S. outbreak strains dating from 2010 to 2012. Genome Announc 2013;1(6):e01075-13
   PubMedGoogle Scholar
• Zhang S, Xu Y, Zhou Z, et al. Complete genome sequence of Bordetella pertussis CS, a Chinese pertussis vaccine strain. J Bacteriol 2011;193(15):4017-18
   PubMedGoogle Scholar
• Chen Q, Decker KB, Boucher PE, et al. Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA. Mol Microbiol 2010;77(5):1326-40
   PubMed Web of Science ®Google Scholar
• Decker KB, Chen Q, Hsieh M-L, et al. Different requirements for σ region 4 in BvgA activation of the Bordetella pertussis promoters P(fim3) and P(fhaB). J Mol Biol 2011;409(5):692-709
   PubMedGoogle Scholar
• Fazekas A, Steeves R, Newmaster S. Improving sequencing quality from PCR products containing long mononucleotide repeats. Biotechniques 2010;48(4):277-85
   PubMedGoogle Scholar
• Van der Woude MW, Bäumler AJ. Phase and antigenic variation in bacteria. Clin Microbiol Rev 2004;17(3):581-611
   PubMed Web of Science ®Google Scholar
• Vaughan TE, Pratt CB, Sealey K, et al. Plasticity of fimbrial genotype and serotype within populations of Bordetella pertussis: analysis by paired flow cytometry and genome sequencing. Microbiology 2014;doi:10.1099/mic.0.079251-0. [Epub ahead of print]
   PubMedGoogle Scholar
• Miller JJ, Silverberg RJ, Saito TM, Humber JB. An agglutinative reaction for Hemophilus pertussis. J Pediatr 1943;22(6):644-51
   Google Scholar
• Vaccination against whooping-cough: report to the Medical Research Council. Br Med J 1956;2(4990):454-62
   PubMedGoogle Scholar
• Brennan MJ, Li ZM, Cowell JL, et al. Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun 1988;56(12):3189-95
   PubMedGoogle Scholar
• Li ZM, Cowell JL, Brennan MJ, et al. Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun 1988;56:3:99-02
   PubMedGoogle Scholar
• Preston NW. Type-specific immunity against whooping cough. Br Med J 1963;2(5359):724-6
   PubMedGoogle Scholar
• World Health Organisation Expert Committee on Biological Standardization Technical Report Series 941. World Health Organization; Geneva, Switzerland: 2007
   Google Scholar
• Robinson A, Irons LI, Ashworth LA. Pertussis vaccine: present status and future prospects. Vaccine 1985;3(1):11-22
   PubMedGoogle Scholar
• Zhang JM, Cowell JL, Steven AC, Manclark CR. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev Biol Stand 1985;61:173-85
   PubMedGoogle Scholar
• Robinson A, Ashworth LA, Baskerville A, Irons LI. Protection against intranasal infection of mice with Bordetella pertussis. Dev Biol Stand 1985;61:165-72
   PubMedGoogle Scholar
• Elomaa A, Advani A, Donnelly D, et al. Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol 2005;43(8):3681-7
   PubMedGoogle Scholar
• Stanbridge TN, Preston NW. Experimental pertussis infection in the marmoset: type specificity of active immunity. J Hyg (Lond) 1974;72(2):213-28
   PubMedGoogle Scholar
• Preston NW, Timewell RM, Carter EJ. Experimental pertussis infection in the rabbit: similarities with infection in primates. J Infect 1980;2(3):227-35
   PubMedGoogle Scholar
• Klein DL. Multicenter acellular pertussis vaccine trial: a National Institutes of Health perspective. Pediatrics 1995;96(3 Pt 2):547-8
   PubMedGoogle Scholar
• Edwards KM, Meade BD, Decker MD, et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995;96(3 Pt 2):548-57
   PubMed Web of Science ®Google Scholar
• Lambert LC. Pertussis vaccine trials in the 1990s. J Infect Dis 2014;209(Suppl 1):S4-9
   PubMed Web of Science ®Google Scholar
• Litt DJ, Neal SE, Fry NK. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol 2009;47(3):680-8
   PubMed Web of Science ®Google Scholar
• Preston NW, Carter EJ. Serotype specificity of vaccine-induced immunity to pertussis. Commun Dis Rep Rev 1992;2(13):R155-6
   PubMedGoogle Scholar
• Poolman JT, Hallander HO. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev Vaccines 2007;6(1):47-56
   PubMed Web of Science ®Google Scholar
• Hallander HO, Gustafsson L. Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience. Expert Rev Vaccines 2009;8(10):1303-7
   PubMed Web of Science ®Google Scholar
• Poynten M, McIntyre PB, Mooi FR, et al. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect 2004;132(2):185-93
   PubMedGoogle Scholar
• Van Gent M, Bart MJ, van der Heide HGJ, et al. Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One 2012;7(9):e46407
   PubMed Web of Science ®Google Scholar
• Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H, et al. Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan. PLoS One 2013;8(10):e77165
   PubMedGoogle Scholar
• Olin P, Rasmussen F, Gustafsson L, et al. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 1997;350(9091):1569-77
   PubMed Web of Science ®Google Scholar
• Tefon BE, Maass S, Ozcengiz E, et al. A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins. Vaccine 2011;29(19):3583-95
   PubMedGoogle Scholar
• Thomas MG, Ashworth LA, Miller E, Lambert HP. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. J Infect Dis 1989;160(5):838-45
   PubMedGoogle Scholar
• Lynn F, Reed GF, Meade BD. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin Diagn Lab Immunol 1996;3(6):689-700
   PubMedGoogle Scholar
• Gustafsson L, Hallander HO, Olin P, et al. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996;334(6):349-55
   PubMed Web of Science ®Google Scholar
• Pearce AM, Irons LI, Robinson A, Seabrook RN. Effects of guanidinium hydrochloride on the structure and immunological properties of Bordetella pertussis fimbriae. Biochem J 1992;283(Pt 3):823-8
   PubMedGoogle Scholar
• Hallander H, Advani A, Alexander F, et al. Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007. Clin Vaccine Immunol 2014;21(2):165-73
   PubMedGoogle Scholar
• Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998;16(20):1907-16
   PubMed Web of Science ®Google Scholar
• Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998;16(20):1901-6
   PubMed Web of Science ®Google Scholar
• Olin P, Hallander HO, Gustafsson L, et al. How to make sense of pertussis immunogenicity data. Clin Infect Dis 2001;33(Suppl 4):S288-91
   PubMedGoogle Scholar
• Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010;17(7):1055-65
   PubMed Web of Science ®Google Scholar
• Fernandez RC, Weiss AA. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect Immun 1994;62(11):4727-38
   PubMed Web of Science ®Google Scholar
• Berggård K, Johnsson E, Mooi FR, Lindahl G. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect Immun 1997;65(9):3638-43
   PubMed Web of Science ®Google Scholar
• Marr N, Luu R, Fernandez RC. Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing. J Infect Dis 2007;195(4):585-8
   PubMedGoogle Scholar
• Amdahl H, Jarva H, Haanperä M, et al. Interactions between Bordetella pertussis and the complement inhibitor factor H. Mol Immunol 2001;48(4):697-705
   Google Scholar
• Hellwig SMM, Rodriguez ME, Berbers GAM, et al. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis 2003;188(5):738-42
   PubMed Web of Science ®Google Scholar
• Aase A, Herstad TK, Merino S, et al. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway. Clin Vaccine Immunol 2007;14(7):855-62
   PubMedGoogle Scholar
• Pratt C, Wilkins C, Taylor S, et al. Antibodies to fimbriae mediate opsonophagocytosis and expression of FHA inhibits opsonophagocytosis. In: 10th International Symposium on pertussis; 2013
   Google Scholar
• De Gouw D, Diavatopoulos DA, Bootsma HJ, et al. Pertussis: a matter of immune modulation. FEMS Microbiol Rev 2011;35(3):441-74
   PubMed Web of Science ®Google Scholar
• Cherry JD, Heininger U, Richards DM, et al. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol 2010;17(5):741-7
   PubMed Web of Science ®Google Scholar
• Higgs R, Higgins SC, Ross PJ, Mills KHG. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol 2012;5(5):485-500
   PubMed Web of Science ®Google Scholar
• Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 2013;6(4):787-96
   PubMed Web of Science ®Google Scholar
• Dillon M, Kolla R, Sidney J, Sette A. Bordetella pertussis fimbriae proteins Fim2 and 3 are immunodominant in T cell responses to acellular pertussis vaccine (LB509). FASEB J Internet 2014;28(1 Suppl):LB509
   Google Scholar
• Heikkinen E, Xing DK, Olander R-M, et al. Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol 2008;8:162
   PubMedGoogle Scholar
• De Greeff SC, de Melker HE, van Gageldonk PGM, et al. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS ONE 2010;5(12):e14183
   PubMed Web of Science ®Google Scholar
• Rønn PF, Dalby T, Simonsen J, et al. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark. Epidemiol Infect 2014;142(4):729-37
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, Xu J, et al. Seroprevalence of pertussis in China: need to improve vaccination strategies. Hum Vaccin Immunother 2014;10(1):192-8
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zheng H, Liu M, et al. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis 2012;12:138
   PubMed Web of Science ®Google Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014;111:787-92
   PubMed Web of Science ®Google Scholar
• Preston NW. Prevalent serotypes of Bordetella pertussis in non-vaccinated communities. J Hyg (Lond) 1976;77(1):85-91
   PubMedGoogle Scholar
• Livey I, Duggleby CJ, Robinson A. Cloning and nucleotide sequence analysis of the serotype 2 fimbrial subunit gene of Bordetella pertussis. Mol Microbiol 1987;1(2):203-9
   PubMedGoogle Scholar
• Walker MJ, Rohde M, Brownlie RM, Timmis KN. Engineering upstream transcriptional and translational signals of Bordetella pertussis serotype 2 fimbrial subunit protein for efficient expression in Escherichia coli: in vitro autoassembly of the expressed product into filamentous structures. Mol Microbiol 1990;4(1):39-47
   PubMedGoogle Scholar
• Mooi FR, Avest A, van der Heide HG. Structure of the Bordetella pertussis gene coding for the serotype 3 fimbrial subunit. FEMS Microbiol Lett 1990;54(1-3):327-31
   PubMedGoogle Scholar
• Tsang RSW, Lau AKH, Sill ML, et al. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 2004;42(11):5364-7
   PubMedGoogle Scholar
• Xu Y, Wang Y, Tan Y, et al. Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis. BMC Microbiol 2009;9:274
   PubMedGoogle Scholar